⌘K

Login Start Free

Home/Filings/4/0001628280-25-028828

4//SEC Filing

Hoffman Robert E. 4

Accession 0001628280-25-028828

CIK 0001434868other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:09 PM ET

Size

20.0 KB

Accession

0001628280-25-028828

Insider Transaction Report

Form 4

Period: 2025-05-29

Esperion Therapeutics, Inc.ESPR

Director

Transactions

Award
Stock Option (right to buy)
2025-05-29+7,040→ 7,040 total
Exercise: $0.87Exp: 2035-05-29→ Common Stock (7,040 underlying)
Award
Common Stock
2025-05-29+5,280→ 5,280 total

Footnotes (1)

[F1]The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025.

Documents

2 files

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1

filerCIK 0001166288

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 4:09 PM ET
Size: 20.0 KB

View on SEC.gov